ASRS
SUPN icon

Arizona State Retirement System’s Supernus Pharmaceuticals SUPN Stock Holding History

Arizona State Retirement System’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$702K Sell
15,094
-655
-4% -$31.5K ﹤0.01% 1375
2026
Q1 		$814K Buy
15,749
+20
+0.1% +$1.02K ﹤0.01% 1207
2025
Q4 		$782K Sell
15,729
-818
-5% -$39.8K ﹤0.01% 1237
2025
Q3 		$791K Buy
16,547
+277
+2% +$11.2K ﹤0.01% 1259
2025
Q2 		$513K Buy
16,270
+430
+3% +$13.8K ﹤0.01% 1441
2025
Q1 		$519K Sell
15,840
-144
-0.9% -$5.1K ﹤0.01% 1399
2024
Q4 		$578K Buy
15,984
+154
+1% +$5.42K ﹤0.01% 1416
2024
Q3 		$494K Buy
15,830
+464
+3% +$14.5K ﹤0.01% 1495
2024
Q2 		$411K Buy
15,366
+338
+2% +$9.8K ﹤0.01% 1541
2024
Q1 		$513K Sell
15,028
-233
-2% -$6.94K ﹤0.01% 1436
2023
Q4 		$442K Sell
15,261
-250
-2% -$6.63K ﹤0.01% 1528
2023
Q3 		$428K Buy
15,511
+238
+2% +$7.25K ﹤0.01% 1466
2023
Q2 		$459K Sell
15,273
-390
-2% -$13.6K ﹤0.01% 1458
2023
Q1 		$567K Buy
15,663
+568
+4% +$21.8K 0.01% 1338
2022
Q4 		$538K Buy
15,095
+580
+4% +$20.2K 0.01% 1329
2022
Q3 		$491K Buy
14,515
+103
+0.7% +$3.35K 0.01% 1333
2022
Q2 		$417K Buy
14,412
+36
+0.3% +$1.03K ﹤0.01% 1460
2022
Q1 		$465K Buy
14,376
+72
+0.5% +$2.21K ﹤0.01% 1518
2021
Q4 		$417K Sell
14,304
-138
-1% -$4.19K ﹤0.01% 1642
2021
Q3 		$385K Buy
14,442
+121
+0.8% +$3.25K ﹤0.01% 1686
2021
Q2 		$441K Sell
14,321
-1,016
-7% -$31.1K ﹤0.01% 1648
2021
Q1 		$402K Buy
15,337
+83
+0.5% +$2.32K ﹤0.01% 1656
2020
Q4 		$384K Sell
15,254
-599
-4% -$12.9K ﹤0.01% 1604
2020
Q3 		$330K Buy
15,853
+4,012
+34% +$91.1K ﹤0.01% 1546
2020
Q2 		$281K Sell
11,841
-475
-4% -$10.5K ﹤0.01% 1470
2020
Q1 		$222K Sell
12,316
-22,668
-65% -$476K ﹤0.01% 1462
2019
Q4 		$830K Sell
34,984
-26,616
-43% -$646K 0.01% 1178
2019
Q3 		$1.69M Sell
61,600
-19,659
-24% -$582K 0.02% 973
2019
Q2 		$2.69M Buy
81,259
+548
+0.7% +$18.8K 0.03% 804
2019
Q1 		$2.83M Buy
80,711
+236
+0.3% +$8.78K 0.03% 750
2018
Q4 		$2.67M Buy
80,475
+4,732
+6% +$203K 0.03% 707
2018
Q3 		$3.81M Buy
75,743
+374
+0.5% +$18.5K 0.04% 635
2018
Q2 		$4.51M Sell
75,369
-5,892
-7% -$305K 0.05% 509
2018
Q1 		$3.72M Sell
81,261
-4,900
-6% -$204K 0.04% 628
2017
Q4 		$3.43M Buy
86,161
+59,860
+228% +$2.37M 0.03% 726
2017
Q3 		$1.05M Buy
26,301
+100
+0.4% +$4.33K 0.01% 1000
2017
Q2 		$1.13M Buy
26,201
+100
+0.4% +$3.56K 0.02% 874
2017
Q1 		$817K Buy
26,101
+600
+2% +$16.1K 0.01% 1031
2016
Q4 		$644K Sell
25,501
-100
-0.4% -$2.23K 0.01% 1125
2016
Q3 		$633K Buy
25,601
+7,600
+42% +$172K 0.01% 1096
2016
Q2 		$367K Buy
18,001
+400
+2% +$7.09K 0.01% 1296
2016
Q1 		$268K Buy
17,601
+1,000
+6% +$13K ﹤0.01% 1361
2015
Q4 		$223K Buy
16,601
+300
+2% +$4.64K ﹤0.01% 1388
2015
Q3 		$229K Buy
+16,301
New +$303K ﹤0.01% 1373

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Arizona State Retirement System's SUPN Position: Q2 2026 in Review

Arizona State Retirement System reduced its Supernus Pharmaceuticals (SUPN) stake by 4.2% in Q2 2026, selling an estimated $31.5K and leaving 15,094 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Arizona State Retirement System first reported a position in SUPN in Q3 2015 and has held it in 44 quarters since. The position peaked at $4.51M in Q2 2018. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Arizona State Retirement System held 15,094 shares of Supernus Pharmaceuticals worth $702K as of Q2 2026.
  • Arizona State Retirement System sold 655 Supernus Pharmaceuticals shares in Q2 2026, an estimated $31.5K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1375 holding.
  • Arizona State Retirement System first reported a position in Supernus Pharmaceuticals in Q3 2015 and has held it in 44 quarters since.
  • Arizona State Retirement System's Supernus Pharmaceuticals position peaked at $4.51M in Q2 2018.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.